It is sometimes hard to see how AI technology benefits society, but applications like drug discovery really bring the power home. Sriram Chandrasekaran, Assistant Professor of Biochemical Engineering at the University of Michigan, is using machine learning to assess the properties of drug candidates to fight antibiotic-resistant bacteria. Presented with millions of different potential drugs, machine learning can identify the few most useful to be tested clinically. Because it tries everything and anything without preconceived biases, ML can uncover novel combinations that researchers might never notice. We also discuss specifics of the AI environment, including the preference for random forests to deep learning, privacy concerns, bias in datasets, and the interplay between domain expertise and data science.
Three Questions
Guests and Hosts
Date: 10/12/2021 Tags: @sriram_lab , @SFoskett, @ChrisGrundemann